| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/11/2012 | CN102311460A Carbonyl-technetium-labeled chlorambucil complex as well as preparation method and application thereof |
| 01/11/2012 | CN102311449A Application of gossypol derivative to preparing anti-tumor medicament |
| 01/11/2012 | CN102311448A Thieno-pyrimidone DPP-IV (dipeptidyl peptidase) inhibitor |
| 01/11/2012 | CN102311447A Heterocyclo pyrimidone dipeptidyl peptidase-IV (DPP-IV) inhibitor |
| 01/11/2012 | CN102311442A Spirolactam alkaloid compound with anti-tumor activity and preparation method as well as application thereof |
| 01/11/2012 | CN102311440A 1-methoxycarbonyl-3-benzyl-8-tertiarybutoxy carbonyl-3,8-diazabicyclo [3.2.1] octane and preparation method |
| 01/11/2012 | CN102311439A 1-substituted-3,8-diazabicyclo[3.2.1] octane derivative and preparation method thereof |
| 01/11/2012 | CN102311438A Quinazoline compound |
| 01/11/2012 | CN102311434A Evodiamine compounds, preparation method thereof and application thereof |
| 01/11/2012 | CN102311423A Preparation method and application of novel antibacterial and anticancer compounds |
| 01/11/2012 | CN102311398A Triazole compounds, preparation method thereof, and application thereof in preparing histone deacetylase I inhibitor |
| 01/11/2012 | CN102311396A Pyrazine derivative and preparation method as well as application thereof to pharmacy |
| 01/11/2012 | CN102311395A Quinazoline ring substituted diphenylurea derivative and its purpose |
| 01/11/2012 | CN102311389A Azoaryl substituted pyrazole derivative and synthesis as well as anti-cancer application thereof |
| 01/11/2012 | CN102309767A Soluble osthole clathrate, dispersing tablet and preparation method thereof |
| 01/11/2012 | CN102309766A Method for improving water solubility of xanthohumol |
| 01/11/2012 | CN102309764A Method for aiding polyethylene glycol (PEG) to modify protein medicament by using organic solvent |
| 01/11/2012 | CN102309763A Medicinal composition and preparation method thereof |
| 01/11/2012 | CN102309761A Uncharged amphiphilic chitosan nano drug carrier and preparation method and application thereof |
| 01/11/2012 | CN102309760A Cationic amphiphilic chitosan nano drug carrier and preparation method and application thereof |
| 01/11/2012 | CN102309757A Novel regulatory factor of FOXP3 and regulatory T cells, and use thereof |
| 01/11/2012 | CN102309755A Design scheme for compound type dual duplex locating type intracellular vaccine |
| 01/11/2012 | CN102309754A Stable medicinal composition of recombinant humanized antibody |
| 01/11/2012 | CN102309748A Application of fibronectin N-end and C-end heparin combining domain peptides to preparation of medicament for resisting liver cancer cell invasion and metastasis |
| 01/11/2012 | CN102309718A Deposition-eliminating congestion-relieving paste |
| 01/11/2012 | CN102309708A Drug for treating tumor |
| 01/11/2012 | CN102309683A Application of traditional Chinese medicinal composition in preparing medicines for treating hysteromyoma |
| 01/11/2012 | CN102309666A Anticancer traditional Chinese medicinal composition and preparation process thereof |
| 01/11/2012 | CN102309665A Anticancer traditional chinese medicine composition and preparation method thereof |
| 01/11/2012 | CN102309656A Chinese medicinal composition with effect of preventing and treating cancers and medicinal application of Chinese medicinal composition |
| 01/11/2012 | CN102309655A Chinese medicinal composition with effect of preventing and treating cancers and application of Chinese medicinal composition |
| 01/11/2012 | CN102309621A Medicament for treating scleromere hyperplasia and use method thereof |
| 01/11/2012 | CN102309539A Spina gleditsiae extract hydrogel patch and preparation method thereof |
| 01/11/2012 | CN102309506A Application of drug composition in preparation of drugs for treating osteoporosis |
| 01/11/2012 | CN102309501A Novel application of artemisinin derivative |
| 01/11/2012 | CN102309500A Application of artemisinin derivative in preparation of chemotherapeutic sensitivity-enhancing drugs |
| 01/11/2012 | CN102309494A Medicinal application of pristimerin as inflammatory cytokine inhibitor |
| 01/11/2012 | CN102309493A Anti-cancer medicinal composition |
| 01/11/2012 | CN102309492A Tegafur, gimeracil and oteracil potassium compound injecta |
| 01/11/2012 | CN102309491A Tegafur and gimeracil compound injecta |
| 01/11/2012 | CN102309487A Liver cancer resistant action of piperine and pharmaceutical preparation thereof |
| 01/11/2012 | CN102309486A Application of piperine in pancreatic cancer resistance and piperine pharmaceutical preparation |
| 01/11/2012 | CN102309485A Colon cancer resistant action of piperine and pharmaceutical preparation thereof |
| 01/11/2012 | CN102309484A Lung cancer resistant action of piperine and pharmaceutical preparation thereof |
| 01/11/2012 | CN102309483A New application of berberine ion pair compound in tumor resistance |
| 01/11/2012 | CN102309479A Application of isoflavone compound in preparation of medicaments or foods for resisting tumors |
| 01/11/2012 | CN102309478A Application of 4',5-dihydroxy-7-[4-(N,N-diethylamino)butoxy]isoflavone in preparation of antineoplastic drugs |
| 01/11/2012 | CN102309474A Application of S-propargyl-cysteine to preparation of medicament for treating digestive system tumors |
| 01/11/2012 | CN102309469A Baohuoside I dry powder inhalant as well as preparation method and application thereof |
| 01/11/2012 | CN102309457A Preparation method for nucleic acid nano-particle wrapping pharmacological active substances |
| 01/11/2012 | CN102309455A Dexamethasone sodium phosphate powder injection and production method thereof |
| 01/11/2012 | CN102309445A Docetaxel intravenous injection composition and preparation method thereof |
| 01/11/2012 | CN102309444A Novel docetaxel injection pharmaceutical composition and application thereof |
| 01/11/2012 | CN102000252B Medicine for treating blood tumor and preparation method thereof |
| 01/11/2012 | CN101933916B Application of gallic acid in preparing anti-HPV medicine |
| 01/11/2012 | CN101864452B Double-specificity anti-tumor recombinant adenovirus and construction method and application thereof |
| 01/11/2012 | CN101863897B New volution compound and preparation method and application thereof |
| 01/11/2012 | CN101862319B Docetaxel combination for injection and preparation method thereof |
| 01/11/2012 | CN101845052B Nitrogen-containing heterocyclic ring thienopyridine ketone derivative, preparation method and application thereof |
| 01/11/2012 | CN101843665B Fig leaf extract lozenges |
| 01/11/2012 | CN101816685B Hydroxyl-containing acid extract for preventing and treating prostate cancer, and extraction method and application thereof |
| 01/11/2012 | CN101810826B Chinese medicament for treating liver cancer |
| 01/11/2012 | CN101781357B Polypeptide for detecting human cancer cells, and application thereof |
| 01/11/2012 | CN101766602B Application of substituted aryl hydrazone compound serving as anti-tumor necrosis factor inhibitor medicament |
| 01/11/2012 | CN101732383B Total sesquiterpene lactone extract of centipeda minima, preparation method and application thereof |
| 01/11/2012 | CN101732307B Medical use of guaifenesin |
| 01/11/2012 | CN101721715B Compound of tumor targeted nonviral gene vector and plasmid DNA and preparation method thereof |
| 01/11/2012 | CN101721710B Cholesteryl-carboxymethyl Curdlan nanometer particle and preparing method |
| 01/11/2012 | CN101708317B Chinese medicinal composition for treating thyroid disease |
| 01/11/2012 | CN101675922B Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use |
| 01/11/2012 | CN101633673B Method for preparing oxaliplatin |
| 01/11/2012 | CN101607931B Preparation method of calcitriol |
| 01/11/2012 | CN101591657B Thymosin beta4 gene expression inhibiting RNA and use thereof |
| 01/11/2012 | CN101574338B Pharmaceutical composition for restraining activity of aromatizing enzyme and application thereof |
| 01/11/2012 | CN101528226B Fluorinated ligands for targeting peripheral benzodiazepine receptors |
| 01/11/2012 | CN101422617B Use of ZNF268 gene splicing isomer in treating leukaemia |
| 01/11/2012 | CN101371840B Novel use of vinetine and analogue thereof in preparing medicine for preventing and/or treating leukemia |
| 01/11/2012 | CN101360718B Novel hydrogen sulfate salt |
| 01/11/2012 | CN101346353B Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 01/11/2012 | CN101340909B Method of inhibiting flt3 kinase |
| 01/11/2012 | CN101317841B Annonaceous acetogenin high-efficiency part medicine-Ainuoning, preparation method and application thereof |
| 01/11/2012 | CN101190281B Prune tree extract and preparation method and application thereof |
| 01/11/2012 | CN101108250B Mono- and disaccharide derivatives |
| 01/11/2012 | CN101049123B Method for preparing tea of natural pine needle powder |
| 01/11/2012 | CN101018780B Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors |
| 01/10/2012 | US8093403 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 01/10/2012 | US8093392 Caspase inhibitors and uses thereof |
| 01/10/2012 | US8093361 Anti-perp antibody |
| 01/10/2012 | US8093274 Inhibitors of protein prenyltransferases |
| 01/10/2012 | US8093244 Heteroaryl urea derivatives useful for inhibiting CHK1 |
| 01/10/2012 | US8093240 Triazole derivatives |
| 01/10/2012 | US8093230 Supersaturated aqueous ifosfamide compositions |
| 01/10/2012 | US8093229 Alkynyl pyrrolo[2,3-d]pyrimidines and related analogs as HSP90-inhibitors |
| 01/10/2012 | US8093217 For sensitizing multi-drug resistant cancer or radiation resistant cancer cells to chemotherapeutic agents |
| 01/10/2012 | US8093216 Diagnosis and classification of cancer; obtain tissue sample, lyse cells, screen lysate for expression of tumor polypeptide, presence of polypeptide indicates tumor |
| 01/10/2012 | US8092798 Method of increasing trabecular bone density in a patient in need thereof by an antibody against GDF-8 |
| 01/10/2012 | US8092780 Polyvalent conjugate vaccine for cancer |
| 01/10/2012 | CA2625502C 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof |
| 01/10/2012 | CA2608180C Substituted acrylamide derivative and pharmaceutical composition comprising the same |
| 01/10/2012 | CA2533332C Therapeutic compounds |